
Ali Ansary, Ozette Technologies CEO
A new AI startup, launched with a trio of Fred Hutch vets, wants to give a 'zoomed-in' view of cancer cells
Ali Ansary, a trained physician, had realized by 2018 that cancers would no longer be treated just with traditional chemotherapy and radiations. Immunotherapy was becoming big, and yet there was no way for doctors to get a complete picture of how immune cells worked at the cellular level when used for cancer therapy, he says.
“How do we get to know more information about this system that is more than inflammatory markers?” he wondered.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters